Anna Honko

Research Associate Professor

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Anna Honko is a Research Associate Professor at Boston University School of Medicine, situated within the National Emerging Diseases Laboratories. Her research focuses on viral pathogens, particularly in relation to Ebola and Marburg viruses, SARS-CoV-2, and their implications in disease transmission and vaccine development. Recent publications highlight her commitment to advancing understanding of virus-host interactions and innovative vaccination strategies.

Articles (12)

Year:

2025

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (9)

Anthony Griffiths

Professor

Boston University Medical Campus

UNITED STATES

View details

Boris Julg

UNITED STATES

View details

University of Texas Medical Branch at Galveston

UNITED STATES

View details

MARIANGELA CAVARELLI

Université Paris-Saclay

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Anna Honko

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Ebola virus’ hidden target: virus transmission to and infection of skin

Low-Input, High-Resolution 5′ Terminal Filovirus RNA Sequencing with ViBE-Seq

A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates

Memory B Cell Repertoire for Recognition of Evolving SARS-CoV-2 Spike

An AAV-based, room-temperature-stable, single-dose COVID-19 vaccine provides durable immunogenicity and protection in non-human primates

Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022

Natural History of Aerosol-Induced Ebola Virus Disease in Rhesus Macaques

Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition.

A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens.

Detecting Pathogen Exposure During the Non-symptomatic Incubation Period Using Physiological Data: Proof of Concept in Non-human Primates.

Fecal SARS-CoV-2 RNA is associated with decreased COVID-19 survival.

Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection

Collaborators (9)

Anthony Griffiths

Boris Julg

David J. Mooney

Felipe Lelis

Elke Muhlberger

Luk Vandenberghe

Goran Bajic

Natalia Kuzmina

MARIANGELA CAVARELLI

Make your next move.